Synthesis of ( Z )- N -hydroxy-3-methoxy-3-phenylacrylamide as new selective inhibitor of hepatitis C virus replication

M. V. Kozlov; A. A. Kleymenova; K. A. Konduktorov; A. Z. Malikova; K. A. Kamarova; R. A. Novikov; S. N. Kochetkov

doi:10.1134/S1068162016010076

Synthesis of (Z)-N-hydroxy-3-methoxy-3-phenylacrylamide as new selective inhibitor of hepatitis C virus replication

作者: Kozlov M.¹, Kleymenova A.¹, Konduktorov K.¹, Malikova A.¹, Kamarova K.¹, Novikov R.¹, Kochetkov S.¹
隶属关系:
1. Engelhardt Institute of Molecular Biology
期: 卷 42, 编号 2 (2016)
页面: 191-197
栏目: Article
URL: https://journals.rcsi.science/1068-1620/article/view/227875
DOI: https://doi.org/10.1134/S1068162016010076
ID: 227875

如何引用文章

全文:

开放存取

##reader.subscriptionAccessGranted##
受限制的访问

订阅存取

详细
作者简介
参考
统计

详细

According to recently published results, cinnamic hydroxamic acid (CHA) inhibits replication of hepatitis C virus (HCV). We synthesized a structural analogue of CHA, i.e., (Z)-N-hydroxy-3-methoxy3-phenylacrylamide, which inhibited HCV replication five times more selectively than CHA. It was found that both compounds did not inhibit deacetylation of Ac-α-tubulin with histone deacetylase 6, the activity of which is important for virus replication.